Mark Garofoli, PharmD, BCGP, CPE, CTTS

Nonopioid pain relief medications include acetaminophen, nonsteroidal anti-inflammatory drugs, suzetrigine, and adjuvant pain management drugs.

Opioid pain care shifts fast, and pharmacists and pharmacies lead safer prescribing, naloxone education, and monitoring to curb overdose deaths.

Pharmacists have the expertise to address acute and chronic pain distinctions, missed-dose protocols, tolerance and safety insights, and multimodal, non-pharmacological strategies for pain.

Combining medical, rehab, psychological, and complementary therapies offers more person-centered relief for chronic pain.

Amid recent comments from FDA Commissioner Marty Makary, MD, MPH, that “everything should be OTC,” Mark Garofoli, PharmD, BCGP, CPE, CTTS, helps pharmacists understand what lies ahead.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, dives deeper into recent comments from the FDA commissioner and what they mean for OTC medication access.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, provides nuance and understanding to the FDA’s recent push to move, essentially, ‘every’ drug to OTC formulation.

Pharmacists play an important role in guiding safe and effective OTC pain management, ensuring optimal patient care and minimizing risks.

Sponsored by YARAL Pharma Inc.

Pharmacists navigate the evolving landscape of cannabis, balancing patient expectations with emerging evidence on cannabidiol and tetrahydrocannabinol for various medical conditions.

Explore the complexities of cannabinoids, focusing on cannabidiol and tetrahydrocannabinol, their effects, side effects, and potential drug interactions in modern use.

Living in West Virginia for over a decade, Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his experience as a practicing pharmacist amid the US opioid crisis.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his pain management expertise and discusses current developments in the US opioid epidemic.

Balancing opioid use with compassion and clinical best practices ensures safe and patient-centered care, supporting pain management and addiction.

In the final part of our interview with Mark Garofoli, PharmD, BCGP, CPE, CTTS, he discusses what the future will hold regarding clinical decision-making following the reported acetaminophen-autism link.

Pain medication expert Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to explore the referenced studies in the Trump Administration’s push to link acetaminophen use with autism.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, also known as “the Pain Guy,” discusses his initial reactions upon learning about the Trump Administration linking acetaminophen use with autism.

A conversation with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, clinical assistant professor and director of experiential learning at West Virginia University School of Pharmacy, at AAP 2025.

Leveraging his expertise in pain management, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to discuss the importance of pharmacists in patients’ use of OTC medications to treat pain.

Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, discusses trends in over-the-counter pain medications amid the ongoing opioid emergency in the US.

At AAP 2025, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, discussed how Disney’s approach to customer service can be applied in a community pharmacy setting.

Pain expert Mark Garofoli, PharmD, BCGP, CPE, CTTS, discussed the pharmacist’s role in managing patients’ use of OTC pain relief products.

Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, discusses effective strategies for balancing excellent patient care with strict regulations surrounding controlled substances.

A conversation with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, at the American Associated Pharmacies 2025 Annual Conference.

Expert on pain medicine, Mark Garofoli, PharmD, BCGP, CPE, CTTS, joined Drug Topics to discuss trends in the safety and efficacy of OTC pain medications and what products patients often seek at the pharmacy.

Experts discuss what they learned at the American Pharmacists Association Annual Meeting and Exposition 2025.

Mark Garofoli, PharmD, BCGP, CPE, director of experiential learning at West Virginia University, discusses the potential of psuychedelic therapy in pharmacy.